Moreau, P. Stewart, K.A. Dimopoulos, M. Siegel, D. Facon, T. Berenson, J. Raje, N. Berdeja, J.G. Orlowski, R.Z. Yang, H. Ma, H. Klippel, Z. Zahlten-Kumeli, A. Mezzi, K. Iskander, K. Mateos, M.-V., Once-weekly (70 mg/m2) vs twice-weekly (56 mg/m2) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials, Cancer Medicine, (9), 2989-2996, 2020, Wiley-Blackwell Publishing Ltd, 2045-7634